Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2
Ependymoma Hub
V1V2
Sign in
← Cases

Dacomitinib

1a588807-10b9-5317-a2d4-d0fdfb28620c · FDA Approved · targets EGFR

Dacomitinib

MeasuredReference

Dacomitinib targets ERBB4_HER4, EGFR, ERBB2_HER2.

Primary targets

ERBB4_HER4EGFRERBB2_HER2TXKDDR1

Top hallmarks

No hallmark data.

Top pathways disrupted

No pathway data.

Resistance landscape — Dacomitinib

MeasuredReference

10 known oncogenic variants exist on Dacomitinib's top targets — see detail for inhibition impact.

Open in new tab